Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 37,441 | 34,388 | 29,345 | 41,150 | 33,026 |
| Cost of Goods | 8,653 | 7,421 | 6,017 | 7,371 | 5,959 |
| Gross Profit | 28,788 | 26,967 | 23,328 | 33,780 | 27,067 |
| Operating Expenses | 35,823 | 36,677 | 34,518 | 38,232 | 29,459 |
| Operating Income | -6,382 | -9,288 | -11,173 | -4,081 | -1,433 |
| Interest Expense | 264 | 246 | 196 | 93 | 106 |
| Other Income | 75 | 243 | 564 | 299 | 205 |
| Pre-tax Income | -6,570 | -9,291 | -10,804 | -3,875 | -1,335 |
| Income Tax | 56 | -79 | 17 | 4,175 | -331 |
| Net Income Continuous | -6,626 | -9,212 | -10,821 | -8,050 | -1,004 |
| Net Income Discontinuous | 3,207 | 5,665 | 3,782 | N/A | N/A |
| Minority Interests | -80 | -9 | -76 | -71 | -59 |
| Net Income | $-3,339 | $-3,538 | $-6,963 | $-7,979 | $-945 |
| EPS Basic Total Ops | -0.22 | -0.23 | -0.45 | -0.50 | -0.06 |
| EPS Basic Continuous Ops | -0.43 | -0.60 | -0.69 | -0.51 | -0.06 |
| EPS Basic Discontinuous Ops | 0.21 | 0.37 | 0.24 | N/A | N/A |
| EPS Diluted Total Ops | -0.22 | -0.23 | -0.45 | -0.50 | -0.06 |
| EPS Diluted Continuous Ops | -0.43 | -0.60 | -0.69 | -0.51 | -0.06 |
| EPS Diluted Discontinuous Ops | 0.21 | 0.37 | 0.24 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.06 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,633 | $-4,884 | $-8,190 | $-1,434 | $964 |